{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:16:34Z","timestamp":1779358594986,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA","award":["207269"],"award-info":[{"award-number":["207269"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2019.01.043","type":"journal-article","created":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T09:06:52Z","timestamp":1549876012000},"page":"1443-1448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants"],"prefix":"10.1016","volume":"37","author":[{"given":"Nandini","family":"Malshe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonali","family":"Palkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Lalwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akhilesh Chandra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Arankalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.01.043_b0005","unstructured":"Atkinson W, Wolfe S, Hamborsky J. Epidemiology and prevention of vaccine-preventable diseases. The Pink Book: course textbook, 12th ed. Washington, DC: Public Health Foundation; 2011."},{"key":"10.1016\/j.vaccine.2019.01.043_b0010","unstructured":"WHO health topics. Immunization. <http:\/\/www.who.int\/topics\/immunization\/en\/> [accessed 28 March 2018]."},{"key":"10.1016\/j.vaccine.2019.01.043_b0015","unstructured":"WHO immunization coverage factsheet. <http:\/\/www.who.int\/mediacentre\/factsheets\/fs378\/en\/> [accessed 28 March 2018]."},{"key":"10.1016\/j.vaccine.2019.01.043_b0020","unstructured":"WHO Global Measles and Rubella Update. April 2018. <http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/active\/Global_MR_Update_April_2018.pdf?ua=1> [accessed 4 June 2018]."},{"key":"10.1016\/j.vaccine.2019.01.043_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s13312-015-0666-2","article-title":"IAP position paper on burden of mumps in india and vaccination strategies","volume":"52","author":"Vashishtha","year":"2015","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0030","unstructured":"Varicella Disease Burden and Varicella Vaccines. WHO SAGE Meeting April 2, 2014. <http:\/\/www.who.int\/immunization\/sage\/meetings\/2014\/april\/2_SAGE_April_VZV_Seward_Varicella.pdf> [accessed 4 June 2018]."},{"key":"10.1016\/j.vaccine.2019.01.043_b0035","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/S0140-6736(15)01190-3","article-title":"Public-funded immunisation: key to varicella control in India","volume":"386","author":"Dehal","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.vaccine.2019.01.043_b0040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s13312-013-0292-9","article-title":"Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years\u2014India, 2013 and updates on immunization","volume":"50","author":"Vashishtha","year":"2013","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0045","first-page":"919","article-title":"Prevalence of placentally transmitted antibodies for measles in infants 3 to 11 months old in an urban slum community","volume":"27","author":"Deivanayagam","year":"1990","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0050","first-page":"155","article-title":"Immune response to measles, mumps & rubella vaccine at 9, 12 & 15 months of age","volume":"100","author":"Singh","year":"1994","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.01.043_b0055","first-page":"1187","article-title":"Transplacental transfer of measles antibody in Delhi","volume":"35","author":"Singh","year":"1999","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0060","first-page":"40","article-title":"A study of measles antibody levels from birth till 9 months of age: correlation with maternal titres and maternal nutrition","volume":"45","author":"Joshi","year":"2003","journal-title":"Bombay Hosp J"},{"key":"10.1016\/j.vaccine.2019.01.043_b0065","first-page":"183","article-title":"Comparative evaluation of measles, mumps & rubella vaccine at 9 & 15 months of age","volume":"118","author":"Yadav","year":"2003","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.vaccine.2019.01.043_b0070","doi-asserted-by":"crossref","first-page":"e007202","DOI":"10.1136\/bmjopen-2014-007202","article-title":"Immunogenicity and safety of early vaccination with two doses of a combined measles-mumps-rubella varicella vaccine in healthy Indian children from 9 months of age: a phase III, randomised, non-inferiority trial","volume":"5","author":"Lalwani","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2019.01.043_b0075","unstructured":"World Population Review. <http:\/\/www.worldpopulationreview.com\/world-cities\/pune-population>."},{"key":"10.1016\/j.vaccine.2019.01.043_b0080","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1128\/CDLI.5.2.135-138.1998","article-title":"Decline of measles-specific immunoglobulin m antibodies after primary measles, mumps, and rubella vaccination","volume":"5","author":"Helfland","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2019.01.043_b0085","doi-asserted-by":"crossref","first-page":"e94714","DOI":"10.1371\/journal.pone.0094714","article-title":"Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants","volume":"9","author":"van den Berg","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.vaccine.2019.01.043_b0090","doi-asserted-by":"crossref","first-page":"428","DOI":"10.32677\/IJCH.2018.v05.i06.008","article-title":"Clinical and laboratory profile of children admitted with measles in a tertiary care teaching hospital","volume":"5","author":"Kumari","year":"2018","journal-title":"Indian J Child Health"},{"key":"10.1016\/j.vaccine.2019.01.043_b0095","doi-asserted-by":"crossref","first-page":"777","DOI":"10.4103\/2249-4863.201161","article-title":"Reporting measles case fatality due to complications from a tertiary care hospital of Kolkata, West Bengal 2011\u20132013","volume":"5","author":"Indwar","year":"2016","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.vaccine.2019.01.043_b0100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/infdis\/jit143","article-title":"Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage","volume":"208","author":"Waaijenborg","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.043_b0105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-11-327","article-title":"Seroprevalence of measles and natural rubella antibodies among children in Bangui, Central African Republic","volume":"11","author":"Manirakiza","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.01.043_b0110","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2010.06.004","article-title":"Kinetics of maternal antibodies against rubella and varicella in infants","volume":"29","author":"Leuridan","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.01.043_b0115","doi-asserted-by":"crossref","first-page":"c1626","DOI":"10.1136\/bmj.c1626","article-title":"Early waning of maternal measles antibodies in era of measles elimination: longitudinal study","volume":"340","author":"Leuridan","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.01.043_b0120","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1365-3083.2006.01857.x","article-title":"Prevalence of IgG antibody against measles, mumps and rubella in Bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy","volume":"64","author":"Sultana","year":"2006","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2019.01.043_b0125","first-page":"1188","article-title":"Effect of an early dose of measles vaccine on morbidity between 18 weeks and 9 months of age: a randomized, controlled trial in Guinea-Bissau","volume":"215","author":"Do","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.043_b0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c6495","article-title":"Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial","volume":"341","author":"Aaby","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2019.01.043_b0135","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/infdis\/jit804","article-title":"A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissions","volume":"209","author":"Martins","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.043_b0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cid\/ciu354","article-title":"measles vaccination in the presence or absence of maternal measles antibody: impact on child survival","volume":"59","author":"Aaby","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.01.043_b0145","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.18444","article-title":"Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage","volume":"8","author":"Plans-Rubi\u00f3","year":"2012","journal-title":"Human Vac Immunother"},{"key":"10.1016\/j.vaccine.2019.01.043_b0150","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1186\/1471-2458-13-358","article-title":"Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps","volume":"13","author":"Awofeso","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2019.01.043_b0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/tropej\/50.3.175","article-title":"Serological response to early measles vaccination","volume":"50","author":"John","year":"2004","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00431-014-2484-2","article-title":"Determining the persistence of maternally acquired antibodies to hepatitis A and varicella zoster during the first 2 years of life in Turkey","volume":"174","author":"Begde","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2019.01.043_b0165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4161\/hv.7.5.14820","article-title":"Inverse correlation between varicella severity and level of anti-Varicella Zoster Virus maternal antibodies in infants below one year of age","volume":"7","author":"Pinquier","year":"2011","journal-title":"Hum Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19301197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:30:15Z","timestamp":1759401015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19301197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X19301197"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.01.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}